Product NDC: | 0068-0510 |
Proprietary Name: | Rifadin |
Non Proprietary Name: | rifampin |
Active Ingredient(s): | 150 mg/1 & nbsp; rifampin |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0068-0510 |
Labeler Name: | Sanofi-Aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA062303 |
Marketing Category: | ANDA |
Start Marketing Date: | 19810715 |
Package NDC: | 0068-0510-30 |
Package Description: | 30 CAPSULE in 1 BOTTLE (0068-0510-30) |
NDC Code | 0068-0510-30 |
Proprietary Name | Rifadin |
Package Description | 30 CAPSULE in 1 BOTTLE (0068-0510-30) |
Product NDC | 0068-0510 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rifampin |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19810715 |
Marketing Category Name | ANDA |
Labeler Name | Sanofi-Aventis U.S. LLC |
Substance Name | RIFAMPIN |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient] |